DEN120022 is an FDA 510(k) submission (not cleared) for the X-RAY ATTENUATING CREAM. Classified as Cream For X-ray Attenuation (product code PDK), Class II - Special Controls.
Submitted by Bloxr Corporation (Salt Lake City, US). The FDA issued a Not Cleared (DENG) decision on May 9, 2013 after a review of 183 days.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.6510 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. This submission did not achieve clearance, indicating the FDA determined the device lacked sufficient predicate equivalence under the Radiology review framework.
View all Bloxr Corporation devices